Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

PERK-opathies: an endoplasmic reticulum stress mechanism underlying neurodegeneration.
Brugada sign in a multiple sclerosis patient: Relation to autonomic nervous system dysfunction and therapeutic dilemmas.
Advancing drug delivery systems for the treatment of multiple sclerosis.
Modulation of Hyperosmotic and Immune-Induced Disruption of the Blood-Brain Barrier by the Nitric Oxide System.
Immunomodulatory effects of adipose-derived mesenchymal stem cells on the gene expression of major transcription factors in T cell subsets.
Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin.
Risk of suicide and suicide attempts associated with physical disorders: a population-based, balancing score-matched analysis.
Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6.
Expression Profile of Long Noncoding RNAs in Peripheral Blood Mononuclear Cells from Multiple Sclerosis Patients.
Ozanimod: a better or just another S1P receptor modulator?
Extracellular vesicles round off communication in the nervous system.
The secretome of mesenchymal stem cells: Potential implications for neuroregeneration.
Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination.
The gateway theory: bridging neural and immune interactions in the CNS.
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity.
Bibliometric profile of the global scientific research on multiple sclerosis (2003-2012).
Interferon-Beta: Neutralizing Antibodies, Binding Antibodies, Pharmacokinetics and Pharmacodynamics, and Clinical Outcomes.
Recovery From Central Nervous System Acute Demyelination in Children.
Differential Pro-Inflammatory Responses of Astrocytes and Microglia Involve STAT3 Activation in Response to 1800 MHz Radiofrequency Fields.
High-Content Phenotypic Screening and Triaging Strategy to Identify Small Molecules Driving Oligodendrocyte Progenitor Cell Differentiation.
Individuals with neurological diseases are at increased risk of fractures within 180 days of admission to long-term care in Ontario.
[Two new oral disease modifying therapies in relapsing remitting multiple sclerosis].
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview.
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?
Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses.

Pages